Patent details

EP4076662 Title: PYRAZOLYL DERIVATIVES USEFUL AS ANTI-CANCER AGENTS

Basic Information

Publication number:
EP4076662
PCT Application Number:
IB2020062144
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP208293654
PCT Publication Number:
WO2021124222
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PYRAZOLYL DERIVATIVES USEFUL AS ANTI-CANCER AGENTS
French Title of Invention:
DÉRIVÉS DE PYRAZOLYLE UTILES EN TANT QU'AGENTS ANTICANCÉREUX
German Title of Invention:
PYRAZOLDERIVATE, VERWENDBAR ALS ANTIKREBSMITTEL
SPC Number:

Dates

Filing date:
17/12/2020
Grant date:
31/01/2024
EP Publication Date:
26/10/2022
PCT Publication Date:
24/06/2021
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/01/2024
EP B1 Publication Date:
31/01/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
17/12/2040
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/01/2024
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
LORTHIOIS, Edwige Liliane Jeanne
Address:
Switzerland (CH)

2

Name:
MAH, Robert
Address:
Switzerland (CH)

3

Name:
STUTZ, Stefan
Address:
Switzerland (CH)

4

Name:
GERSPACHER, Marc
Address:
Switzerland (CH)

5

Name:
COTESTA, Simona
Address:
Switzerland (CH)

6

Name:
VAUPEL, Andrea
Address:
Switzerland (CH)

7

Name:
MACHAUER, Rainer
Address:
Switzerland (CH)

8

Name:
WILCKEN, Rainer
Address:
Switzerland (CH)

9

Name:
SCHNEIDER, Nadine
Address:
Switzerland (CH)

10

Name:
RIGOLLIER, Pascal
Address:
Switzerland (CH)

11

Name:
MURA, Christophe
Address:
Switzerland (CH)

12

Name:
WARIN, Nicolas
Address:
Switzerland (CH)

13

Name:
LEBLANC, Catherine
Address:
Switzerland (CH)

14

Name:
LIU, Bo
Address:
China (CN)

Priority

1

Priority Number:
201962951400 P
Priority Date:
20/12/2019
Priority Country:
United States (US)

2

Priority Number:
PCT/CN2020/125425
Priority Date:
30/10/2020
Priority Country:
World Intellectual Property Office (WIPO) (WO)

Classification

IPC classification:
A61P 35/00; C07D 401/14; C07D 403/04; C07D 403/14; C07D 405/14; C07D 413/14; C07D 417/14; C07D 471/04; C07D 487/04; A61K 31/416; A61K 31/4439; A61K 31/506; A61K 31/437; A61K 31/502; A61K 31/517; A61K 31/538; A61K 31/425;

Publication

European Patent Bulletin

1

Issue number:
202405
Publication date:
31/01/2024
Description:
Grant (B1)

2

Issue number:
202408
Publication date:
21/02/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/12/2025
Annual Fee Number:
6
Annual Fee Amount:
66 Euro
Expected Payer:
Last Annual Fee Payment Date:
16/04/2025
Last Annual Fee Paid Number:
5
Last Annual Fee Paid Amount:
52 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages